The Rosen Law Firm has announced an investigation into potential securities claims against The Ensign Group, Inc. on behalf of shareholders, following allegations that the company may have issued materially misleading business information. The investigation stems from a June 8, 2026 short seller report by Hunterbrook alleging that Ensign's business model relies on inadequate patient care and gaming quality metrics, with claims that patients have suffered and died as a result. On that day, Ensign Group shares fell 8.15%. The Rosen Law Firm is preparing a class action to recover investor losses and encourages affected shareholders to contact the firm.
The Ensign Group IncInvestigation and class action over alleged misleading business information and inadequate patient care.